Written by Lisa Colbert.
The Ohio Third Frontier Commission approved $21 million to establish the Neurotechnology Innovations Translator led by The Ohio State University in Columbus. The project will take breakthrough research developed at The Ohio State University and expand solutions that could improve the quality of life for people affected by some of the most prevalent neurological disorders, including Parkinson’s disease, epilepsy, Alzheimer’s disease, autism and chronic pain.
This is one of the first two awards from the new Technology Commercialization Center Program. The Commission also approved $25 million to support the Harrington Discovery Institute – Innovation Support Center led by University Hospitals in Cleveland. Both projects will make contributions to the quality of clinical care globally, build strategic partnerships with major players in the healthcare industry, create high growth medical technology start-ups, and attract venture capital to Ohio.
Click here to learn more.